BioSpace News Archive

Business

Biostage Reports 2018 Third Quarter Financial Results

- Scientific feedback along with new and consistent data continue to validate technology

November 8, 2018
·
9 min read
Pharm Country

New Poll Sheds Light On Flu Shot Disparity: 85 Percent Of Americans Know That Healthy Children Can Die From The Flu, Yet Half Of Parents Polled Still Haven’t Gotten Their Children Vaccinated

CareDox and Families Fighting Flu Launch Campaign to Raise Public Awareness of Misconceptions Tied to Flu Vaccinations

November 8, 2018
·
6 min read
Business

Sierra Oncology Reports Third Quarter 2018 Results

Momelotinib regulatory pathway clarity anticipated in H1 2019

November 8, 2018
·
11 min read
Pharm Country

Acorda to Present at Stifel 2018 Healthcare Conference

Acorda Therapeutics, Inc. announced that Acorda’s President and CEO will present at the Stifel 2018 Healthcare Conference.

November 8, 2018
·
3 min read
Business

Seres Therapeutics Reports Third Quarter Financial Results and Provides Operational Updates

Kevin Horgan, M.D. an accomplished drug developer and immunology expert, hired as Chief Medical Officer

November 8, 2018
·
12 min read
Drug Development

ArQule to Present Clinical and Preclinical Data for ARQ 751 at the 30th EORTC/AACR/NCI Symposium

Three poster presentations highlighting clinical data from ARQ 751-101 and preclinical data on ARQ 751 in combination with other agents

November 8, 2018
·
6 min read
Business

Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results

Preliminary Phase 1 Clinical Study Results Presented at the European Society of Medical Oncology (ESMO) 2018 Congress Demonstrate the Potential of DCC-2618 to Provide Improved and Durable Clinical Outcomes in Second- and Third-Line Patients

November 8, 2018
·
12 min read
Biotech Bay

Actym Therapeutics Will Present Data at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Presentation will focus on a novel tumor-targeting, systemically-delivered STING pathway agonist that demonstrates robust anti-tumor efficacy in multiple murine cancer models

November 8, 2018
·
2 min read
Drug Development

Palatin Technologies, Inc. Announces First-in-Human Study Results of Subcutaneous Administration of PL-8177, An Investigational Melanocortin Receptor 1 Agonist

Oral Formulation Clinical Data Currently Anticipated by Year End

November 8, 2018
·
5 min read
Orexo to Host a Capital Markets Day on Dec. 6 With the US President´s Former Advisor as Keynote Speaker

Orexo will provide an update on the Company’s strategy for growth, market trends and position and its increased focus on R&D, including new innovative formulation technologies.

November 8, 2018
·
2 min read